Filing Details

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G

 

INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT N0. 5)¹

 

Coeptis Therapeutics Holdings, Inc.

(Name of Issuer)

 

 

Common Shares, $0.0001 par value per share

(Title of Class of Securities)

 

 

19207A108

(CUSIP Number)

 

 

October 28, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[  ]	Rule 13d-1(b)
[X]	Rule 13d-1(c)
[  ]	Rule 13d-1(d)

 

        ¹  The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)

 

 

 

CUSIP No. 629709205
1.	NAMES OF REPORTING PERSONS Lena Pharma, LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [  ] (b) [  ]
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION Pennsylvania
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5.    SOLE VOTING POWER	1,431,691
		6.    SHARED VOTING POWER	0
		7.    SOLE DISPOSITIVE POWER	1,431,691
		8.    SHARED DISPOSITIVE POWER	0
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,431,691
10.	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [  ]
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.33%
12.	TYPE OF REPORTING PERSON OO

 

 

Item 1.
	(a)	Name of Issuer Coeptis Therapeutics Holdings, Inc.
	(b)	Address of Issuer’s Principal Executive Offices 105 Bradford Rd, Suite 420, Wexford, Pennsylvania 15090
Item 2.
	(a)	Name of Person Filing Lena Pharma, LLC
	(b)	Address of Principal Business Office or, if None, Residence 470 Mohawk Circle, Stoystown, PA 15563
	(c)	Citizenship Pennsylvania limited liability company
	(d)	Title of Class of Securities Common Shares, $0.0001 par value per share
	(e)	CUSIP Number:  19207A108

 

 

Item 3.

If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

 

	(a)	[  ]	Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
	(b)	[  ]	Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
	(c)	[  ]	Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
	(d)	[  ]	Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
	(e)	[  ]	An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E);
	(f)	[  ]	An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);
	(g)	[  ]	A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);
	(h)	[  ]	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	[  ]	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	[  ]	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J).

 

Item 4

Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1

 

	(a)	Amount Beneficially Owned:
		1,431,691
	(b)	Percent of Class:
		7.34%
	(c)	Number of shares as to which such person has:

 

	(i)	sole power to vote or to direct the vote	1,431,691
	(ii)	shared power to vote or to direct the vote	0
	(iii)	sole power to dispose or to direct the disposition of	1,431,691
	(iv)	shared power to dispose or to direct the disposition of	0

 

 

 

 

Item 5.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [X]

 

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.
	Not Applicable.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.   Not Applicable.
Item 8.	Identification and Classification of Members of the Group. Not Applicable.
Item 9.	Notice of Dissolution of Group. Not Applicable.
Item 10.	Certification. Not Applicable.

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

	November 7, 2022
	(Date)
	/s/ Lena Kuchera
	(Signature)
	Lena Kuchera, Manager
	(Name/Title)